Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioMarin Pharmaceutical Inc. buy Bank of America Co.

BioMarin Pharmaceutical Inc.
Start price
€68.34
20.02.25 / 50%
Target price
€98.56
20.02.26
Performance (%)
-21.69%
End price
€53.52
21.02.26
Summary
This prediction ended on 21.02.26 with a price of €53.52. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -21.69%. Bank_of_America_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
BioMarin Pharmaceutical Inc. 5.138% 5.138% -19.321%
iShares Core DAX® 0.024% 0.583% 11.674%
iShares Nasdaq 100 1.740% -2.061% 4.180%
iShares Nikkei 225® 0.428% 10.487% 29.994%
iShares S&P 500 1.329% 0.140% 3.333%

Comments by Bank_of_America_Co_ for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -21.69%
Target price 98.561
Change
Ends at 20.02.26

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at Bank of America Co. from $99.00 to $103.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat

Bank of America Co. 
0
Report Share
20.02.25
In the thread Trading BioMarin Pharmaceutical Inc.
Prediction Buy
Perf. (%) -21.69%
Target price 98.561
Change
Ends at 20.02.26

Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten

Bank of America Co. 
0
Report Share
21.02.26

Stopped prediction by Bank_of_America_Co_ for BioMarin Pharmaceutical Inc.

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€62.80
17.09.24
€103.34
17.09.25
-26.54%
18.09.25

Bank of America Co. 
17.09.24 50%